Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% | -47.06% | -.--% |
2019 | SalvaRx Evaluates Takeover Opportunities | CI |
2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
Sales 2017 | - | Sales 2018 | - | Capitalization | 28.53M 39M |
---|---|---|---|---|---|
Net income 2017 | -1M -1.37M | Net income 2018 | - 0 | EV / Sales 2017 | - |
Net Debt 2017 | 2.22M 3.04M | Net Debt 2018 | 763K 1.04M | EV / Sales 2018 | - |
P/E ratio 2017 |
-4.13
x | P/E ratio 2018 |
83
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 20.33% |
Managers | Title | Age | Since |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 19-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
CHM | Chairman | 68 | - |
Peter Redmond
BRD | Director/Board Member | 76 | - |
Gregory Bailey
FOU | Founder | 68 | 06-12-31 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.16M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SALV Stock